KOD: Kodiak Sciences Inc. Stock

by  •  • Comments Off on KOD: Kodiak Sciences Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 124.20
Enterprise Value ($M) -43.88
Book Value ($M) 150.29
Book Value / Share 2.86
Price / Book 0.83
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.80
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.73

Liquidity (mrq)
Quick Ratio 0.00
Current Ratio 6.72

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -186.85
Net Income n/a
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -117.32
Cash from Investing n/a
Cash from Financing 0.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perlroth Victor 11.00 7.05

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 303,303 675,034 44.93
2025-04-16 55,923 227,404 24.59
2025-04-15 117,511 282,751 41.56
2025-04-14 29,625 191,018 15.51

(click for more detail)

Similar Companies
JANX – Janux Therapeutics, Inc. KALV – KalVista Pharmaceuticals, Inc.
KLTO – Klotho Neurosciences, Inc. KROS – Keros Therapeutics, Inc.
KYMR – Kymera Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io